The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

J. Meunier, Pierre; Roux, Christian; Seeman, Ego; Ortolani, S.; Badurski, J; D. Spector, Tim; B. Cannata‐Andía, Jorge; Balogh, Á.; Lemmel, Ernst-Martin; Pors-Nielsen, S.; Rizzoli, René; K. Genant, Harry; Reginster, Jean‐Yves

doi:10.1056/nejmoa022436

Public

The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

Published in New England Journal of Medicine • Jan 29, 2004

Authors:

Pierre J. Meunier

Christian Roux

Ego Seeman

Abstract

BACKGROUND: Osteoporotic structural damage and bone fragility result from reduced bone formation and increased bone resorption. In a phase 2 clinical trial, strontium ranelate, an orally active drug that dissociates bone remodeling by increasing bone formation and decreasing bone resorption, has bee...

Subject

Strontium ranelate

Medicine

Osteoporosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!